The procedure for conducting negotiations on Controlled Access Agreement, the types of such agreements and the procedure for their conclusion, implementation, amendment and termination, as well as the standard form of such an agreement, shall be approved by the Cabinet of Ministers of Ukraine. In case of state registration in Ukraine of a generic medication (similar biological medication) with the international non-proprietary name, pharmaceutical form and dosage similar to the medication subject to the Controlled Access Agreement, the Controlled Access Agreement shall be terminated before expiry on December 31 of the current budget year, if the validity period of this agreement does not expire before the specified date. The conclusion, execution, change and termination of the Controlled Access Agreement shall be carried out under provisions of the legislation of Ukraine.